Kiora Pharmaceuticals, Inc. (KPRX)
2.15
+0.03
(+1.42%)
USD |
NASDAQ |
Feb 06, 16:00
2.16
+0.01
(+0.47%)
After-Hours: 20:00
Kiora Pharmaceuticals Total Assets (Quarterly) : 29.86M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 648.44M |
| Plus Therapeutics, Inc. | 18.67M |
| Atossa Therapeutics, Inc. | 58.01M |
| Abeona Therapeutics, Inc. | 231.10M |
| Cell Source, Inc. | 0.2865M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.453M |
| Shareholders Equity (Quarterly) | 22.41M |
| Debt to Equity Ratio | 0.018 |
| Current Ratio | 8.795 |
| Net Debt Paydown Yield | -0.67% |